Literature DB >> 25690563

Nanomedicine as an innovative therapeutic strategy for pediatric cancer.

Essa Mohd Aleassa1, Malcolm Xing, Richard Keijzer.   

Abstract

Childhood cancer is the leading cause of mortality in children between 1 and 14 years of age. Malignancy accounts for 18 % of overall childhood mortality. Therapeutic advances in the field of pediatric oncology have helped to increase survival. Nanotechnology is the modification of materials at a nanoscale and can be used to deliver therapeutic agents. Examples of nanotechnology applications are organic self-assembled amphiphilic polymers, non-organic nanocarriers such as nanotubes and quantum dots. Each of these has their own utility in different settings. Application of nanotechnology in medicine has been extensively studied. Examples of pediatric tumors that received special attention are: neuroblastoma, retinoblastoma, central nervous system tumors and musculoskeletal tumors. This review will summarize the application of nanomedicine as an innovative management strategy in pediatric oncology.

Entities:  

Mesh:

Year:  2015        PMID: 25690563     DOI: 10.1007/s00383-015-3683-2

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  42 in total

1.  Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992.

Authors:  J G Gurney; J A Ross; D A Wall; W A Bleyer; R K Severson; L L Robison
Journal:  J Pediatr Hematol Oncol       Date:  1997 Sep-Oct       Impact factor: 1.289

2.  Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.

Authors:  Andrey Korshunov; Marc Remke; Wiebke Werft; Axel Benner; Marina Ryzhova; Hendrik Witt; Dominik Sturm; Andrea Wittmann; Anna Schöttler; Jörg Felsberg; Guido Reifenberger; Stefan Rutkowski; Wolfram Scheurlen; Andreas E Kulozik; Andreas von Deimling; Peter Lichter; Stefan M Pfister
Journal:  J Clin Oncol       Date:  2010-05-17       Impact factor: 44.544

3.  Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project.

Authors:  Claudia Spix; Guido Pastore; Risto Sankila; Charles A Stiller; Eva Steliarova-Foucher
Journal:  Eur J Cancer       Date:  2006-09       Impact factor: 9.162

4.  Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma.

Authors:  Shin J Kang; Chandrasekar Durairaj; Uday B Kompella; Joan M O'Brien; Hans E Grossniklaus
Journal:  Arch Ophthalmol       Date:  2009-08

5.  Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study.

Authors:  Amar Gajjar; Clinton F Stewart; David W Ellison; Sue Kaste; Larry E Kun; Roger J Packer; Stewart Goldman; Murali Chintagumpala; Dana Wallace; Naoko Takebe; James M Boyett; Richard J Gilbertson; Tom Curran
Journal:  Clin Cancer Res       Date:  2013-09-27       Impact factor: 12.531

6.  Is medulloblastoma the same tumor in children and adults?

Authors:  M T Giordana; P Cavalla; A Dutto; L Borsotti; A Chiò; D Schiffer
Journal:  J Neurooncol       Date:  1997-11       Impact factor: 4.130

7.  Retinoblastoma incidence patterns in the US Surveillance, Epidemiology, and End Results program.

Authors:  Jeannette R Wong; Margaret A Tucker; Ruth A Kleinerman; Susan S Devesa
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

Review 8.  Retinoblastoma: review of current management.

Authors:  Murali Chintagumpala; Patricia Chevez-Barrios; Evelyn A Paysse; Sharon E Plon; Richard Hurwitz
Journal:  Oncologist       Date:  2007-10

9.  Incidence of retinoblastoma and survival rate of retinoblastoma patients in Korea using the Korean National Cancer Registry database (1993-2010).

Authors:  Sang Jun Park; Se Joon Woo; Kyu Hyung Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-01       Impact factor: 4.799

10.  MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2.

Authors:  Yucui Jin; Anwen Xiong; Ziyu Zhang; Sanen Li; Huijie Huang; Ting-ting Yu; Xiumei Cao; Steven Y Cheng
Journal:  Oncotarget       Date:  2014-07-15
View more
  1 in total

Review 1.  Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma.

Authors:  Hui Yan; Bo Zhai; Fang Yang; Zhenliang Chen; Qiang Zhou; Ana Cláudia Paiva-Santos; Ziqiao Yuan; Yang Zhou
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.